Morgan Stanley (MS) 31.89 $MS Communications Sa
Post# of 273257
Posted On: 09/04/2016 1:13:38 PM
Morgan Stanley (MS) 31.89 $MS
Communications Sales & Leasing Announces $250 Million ATM Equity Offering Program
GlobeNewswire - Fri Sep 02, 4:04PM CDT
Communications Sales & Leasing, Inc. ("CS&L" or the "Company"
(Nasdaq:CSAL) today announced the establishment of an "at the market" equity offering program, pursuant to which the Company may offer and sell shares of its common stock, par value $0.0001 per share, with an aggregate gross sales amount of up to $250 million through equity distribution agreements with BofA Merrill Lynch, Goldman, Sachs & Co., Morgan Stanley, and Wells Fargo Securities.
CSAL: 31.90 (+0.57), MS: 31.89 (-0.02)
Financial ETFs Surged in August: Will the Rally Last?
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 11:08AM CDT
The financial sector outperformed other broader S&P 500 sectors last month and led ETFs from the space to surge.
KRE: 43.09 (+0.37), KBE: 34.23 (+0.27), VFH: 50.85 (+0.29), ADP: 90.39 (-0.24), C: 47.51 (+0.15), BAC: 16.00 (+0.02), XLF: 24.57 (+0.11), IYF: 92.41 (+0.57), MS: 31.89 (-0.02)
Ligand to Participate in Two Upcoming Investor Conferences
BusinessWire - Fri Sep 02, 8:00AM CDT
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences:
LGND: 106.19 (-0.85), MS: 31.89 (-0.02)
Canadian Solar to Attend Morgan Stanley China Corporate Day in London
PR Newswire - Fri Sep 02, 4:00AM CDT
Canadian Solar Inc. (NASDAQ: CSIQ), one of the world's largest solar power companies, today announced that it is scheduled to attend Morgan Stanley China Corporate Day on Monday, September 5, 2016 at Morgan Stanley's offices at 25 Cabot Square, Canary Wharf in London.
CSIQ: 13.14 (+0.17), MS: 31.89 (-0.02)
Aetna Executive to Present at Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Sep 01, 3:30PM CDT
Aetna (NYSE: AET) announced today that Shawn M. Guertin, executive vice president and chief financial officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13 at 12:55 p.m. ET.
AET: 116.73 (+0.57), MS: 31.89 (-0.02)
PerkinElmer to Present at Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Sep 01, 3:15PM CDT
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 11:40am ET at the Grand Hyatt Hotel in New York City.
PKI: 53.46 (+0.20), MS: 31.89 (-0.02)
Surgery Partners, Inc. to Present at the 2016 Morgan Stanley Global Healthcare Conference
GlobeNewswire - Thu Sep 01, 9:00AM CDT
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners", a leading healthcare services company, today announced that CEO Mike Doyle and CFO Teresa Sparks will present at the 2016 Morgan Stanley Global Healthcare Conference, on Sept. 13th, 2016, in New York, NY. The presentation will begin at 1:30 PM ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by logging on to the Investor Relations section of the company's website at www.surgerypartners.com. The on-line replay will be available immediately following the presentation and for the following 90 days.
SGRY: 20.04 (+0.91), MS: 31.89 (-0.02)
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
GlobeNewswire - Thu Sep 01, 8:35AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 10:30 a.m. EDT.
AMAG: 23.66 (-0.05), MS: 31.89 (-0.02)
Allergan to Present at Morgan Stanley Global Healthcare Conference
PR Newswire - Thu Sep 01, 6:30AM CDT
Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's CEO and President, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 11:45 a.m. ET at the Grand Hyatt in New York, NY.
AGN: 235.96 (-1.80), MS: 31.89 (-0.02)
Insys Therapeutics, Inc. to Present at Morgan Stanley Global Healthcare Conference
GlobeNewswire - Thu Sep 01, 6:00AM CDT
Insys Therapeutics, Inc. ("Insys" or "the Company" (NASDAQ:INSY) today announced that Darryl Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, will present at the Morgan Stanley Global Healthcare Conference as follows:
INSY: 14.63 (+0.27), MS: 31.89 (-0.02)
Keller Rohrback L.L.P. Investigates Morgan Stanley's $8 Billion 401(k) Plan
BusinessWire - Wed Aug 31, 5:59PM CDT
Attorney Advertising. Keller Rohrback L.L.P. is investigating recent reports that Morgan Stanley (NYSE:MS) mismanaged its employees' 401(k) Plan and engaged in illegal self-dealing.
MS: 31.89 (-0.02)
Egalet Completes $40 Million Secured Debt Financing
PR Newswire - Wed Aug 31, 3:48PM CDT
Egalet Corporation (Nasdaq: EGLT) ("Egalet", a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced the completion of a secured debt offering of $40 million. Egalet plans to use the net proceeds from this transaction to repay all outstanding obligations to Hercules Capital, Inc. under its existing loan agreement, to support the approval and planned commercialization of ARYMO(TM) ER (Morphine Sulfate) extended-release tablets, an abuse-deterrent morphine, to support the development of Egalet-002, an abuse-deterrent, extended-release oxycodone, and for general corporate purposes. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.
EGLT: 6.58 (-0.03), MS: 31.89 (-0.02)
Exelixis to Present at the Morgan Stanley Global Healthcare Conference on September 13
BusinessWire - Wed Aug 31, 3:17PM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will provide an overview of the company at the Morgan Stanley Global Healthcare Conference taking place September 12-14 in New York, NY. The Exelixis presentation is scheduled for 9:10 AM EDT/6:10 AM PDT on Tuesday, September 13, 2016.
EXEL: 11.54 (+0.19), MS: 31.89 (-0.02)
Ocular Therapeutix(TM) to Participate in the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:05PM CDT
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 4:15 p.m. ET. The conference will be held at the Grand Hyatt Hotel in New York, NY.
OCUL: 6.38 (+0.02), MS: 31.89 (-0.02)
Kite Pharma to Participate in September 2016 Investor Conferences
BusinessWire - Wed Aug 31, 3:05PM CDT
Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will participate in a panel at the 11th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.
KITE: 58.76 (-0.11), MS: 31.89 (-0.02)
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
PR Newswire - Wed Aug 31, 3:01PM CDT
Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on Monday, September 12, 2016 at 1:40pm Eastern time.
HAE: 37.80 (+0.48), MS: 31.89 (-0.02)
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 14, 2016 in New York, NY.
CNMD: 40.99 (+0.43), MS: 31.89 (-0.02)
Cigna Corporation Announces Appearance at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 10:34AM CDT
Cigna Corporation (NYSE: CI) announced today that David Cordani, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on September 14, 2016 in New York, NY.
CI: 128.18 (+0.54), MS: 31.89 (-0.02)
Top Research Reports for Apple, Shell & Morgan Stanley
Sheraz Mian - Zacks Investment Research - Wed Aug 31, 10:32AM CDT
Top Research Reports for Apple, Shell & Morgan Stanley
KO: 43.66 (+0.31), RDS.A: 49.64 (+1.01), AAPL: 107.73 (+1.00), ORCL: 41.25 (+0.09), MS: 31.89 (-0.02), TRV: 118.84 (+0.49)
Communications Sales & Leasing Announces $250 Million ATM Equity Offering Program
GlobeNewswire - Fri Sep 02, 4:04PM CDT
Communications Sales & Leasing, Inc. ("CS&L" or the "Company"
(Nasdaq:CSAL) today announced the establishment of an "at the market" equity offering program, pursuant to which the Company may offer and sell shares of its common stock, par value $0.0001 per share, with an aggregate gross sales amount of up to $250 million through equity distribution agreements with BofA Merrill Lynch, Goldman, Sachs & Co., Morgan Stanley, and Wells Fargo Securities. CSAL: 31.90 (+0.57), MS: 31.89 (-0.02)
Financial ETFs Surged in August: Will the Rally Last?
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 11:08AM CDT
The financial sector outperformed other broader S&P 500 sectors last month and led ETFs from the space to surge.
KRE: 43.09 (+0.37), KBE: 34.23 (+0.27), VFH: 50.85 (+0.29), ADP: 90.39 (-0.24), C: 47.51 (+0.15), BAC: 16.00 (+0.02), XLF: 24.57 (+0.11), IYF: 92.41 (+0.57), MS: 31.89 (-0.02)
Ligand to Participate in Two Upcoming Investor Conferences
BusinessWire - Fri Sep 02, 8:00AM CDT
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences:
LGND: 106.19 (-0.85), MS: 31.89 (-0.02)
Canadian Solar to Attend Morgan Stanley China Corporate Day in London
PR Newswire - Fri Sep 02, 4:00AM CDT
Canadian Solar Inc. (NASDAQ: CSIQ), one of the world's largest solar power companies, today announced that it is scheduled to attend Morgan Stanley China Corporate Day on Monday, September 5, 2016 at Morgan Stanley's offices at 25 Cabot Square, Canary Wharf in London.
CSIQ: 13.14 (+0.17), MS: 31.89 (-0.02)
Aetna Executive to Present at Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Sep 01, 3:30PM CDT
Aetna (NYSE: AET) announced today that Shawn M. Guertin, executive vice president and chief financial officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13 at 12:55 p.m. ET.
AET: 116.73 (+0.57), MS: 31.89 (-0.02)
PerkinElmer to Present at Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Sep 01, 3:15PM CDT
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 11:40am ET at the Grand Hyatt Hotel in New York City.
PKI: 53.46 (+0.20), MS: 31.89 (-0.02)
Surgery Partners, Inc. to Present at the 2016 Morgan Stanley Global Healthcare Conference
GlobeNewswire - Thu Sep 01, 9:00AM CDT
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners"
, a leading healthcare services company, today announced that CEO Mike Doyle and CFO Teresa Sparks will present at the 2016 Morgan Stanley Global Healthcare Conference, on Sept. 13th, 2016, in New York, NY. The presentation will begin at 1:30 PM ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by logging on to the Investor Relations section of the company's website at www.surgerypartners.com. The on-line replay will be available immediately following the presentation and for the following 90 days. SGRY: 20.04 (+0.91), MS: 31.89 (-0.02)
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
GlobeNewswire - Thu Sep 01, 8:35AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 10:30 a.m. EDT.
AMAG: 23.66 (-0.05), MS: 31.89 (-0.02)
Allergan to Present at Morgan Stanley Global Healthcare Conference
PR Newswire - Thu Sep 01, 6:30AM CDT
Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's CEO and President, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 11:45 a.m. ET at the Grand Hyatt in New York, NY.
AGN: 235.96 (-1.80), MS: 31.89 (-0.02)
Insys Therapeutics, Inc. to Present at Morgan Stanley Global Healthcare Conference
GlobeNewswire - Thu Sep 01, 6:00AM CDT
Insys Therapeutics, Inc. ("Insys" or "the Company"
(NASDAQ:INSY) today announced that Darryl Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, will present at the Morgan Stanley Global Healthcare Conference as follows: INSY: 14.63 (+0.27), MS: 31.89 (-0.02)
Keller Rohrback L.L.P. Investigates Morgan Stanley's $8 Billion 401(k) Plan
BusinessWire - Wed Aug 31, 5:59PM CDT
Attorney Advertising. Keller Rohrback L.L.P. is investigating recent reports that Morgan Stanley (NYSE:MS) mismanaged its employees' 401(k) Plan and engaged in illegal self-dealing.
MS: 31.89 (-0.02)
Egalet Completes $40 Million Secured Debt Financing
PR Newswire - Wed Aug 31, 3:48PM CDT
Egalet Corporation (Nasdaq: EGLT) ("Egalet"
, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced the completion of a secured debt offering of $40 million. Egalet plans to use the net proceeds from this transaction to repay all outstanding obligations to Hercules Capital, Inc. under its existing loan agreement, to support the approval and planned commercialization of ARYMO(TM) ER (Morphine Sulfate) extended-release tablets, an abuse-deterrent morphine, to support the development of Egalet-002, an abuse-deterrent, extended-release oxycodone, and for general corporate purposes. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction. EGLT: 6.58 (-0.03), MS: 31.89 (-0.02)
Exelixis to Present at the Morgan Stanley Global Healthcare Conference on September 13
BusinessWire - Wed Aug 31, 3:17PM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will provide an overview of the company at the Morgan Stanley Global Healthcare Conference taking place September 12-14 in New York, NY. The Exelixis presentation is scheduled for 9:10 AM EDT/6:10 AM PDT on Tuesday, September 13, 2016.
EXEL: 11.54 (+0.19), MS: 31.89 (-0.02)
Ocular Therapeutix(TM) to Participate in the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:05PM CDT
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 4:15 p.m. ET. The conference will be held at the Grand Hyatt Hotel in New York, NY.
OCUL: 6.38 (+0.02), MS: 31.89 (-0.02)
Kite Pharma to Participate in September 2016 Investor Conferences
BusinessWire - Wed Aug 31, 3:05PM CDT
Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will participate in a panel at the 11th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.
KITE: 58.76 (-0.11), MS: 31.89 (-0.02)
Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
PR Newswire - Wed Aug 31, 3:01PM CDT
Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on Monday, September 12, 2016 at 1:40pm Eastern time.
HAE: 37.80 (+0.48), MS: 31.89 (-0.02)
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 14, 2016 in New York, NY.
CNMD: 40.99 (+0.43), MS: 31.89 (-0.02)
Cigna Corporation Announces Appearance at the Morgan Stanley Global Healthcare Conference
BusinessWire - Wed Aug 31, 10:34AM CDT
Cigna Corporation (NYSE: CI) announced today that David Cordani, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on September 14, 2016 in New York, NY.
CI: 128.18 (+0.54), MS: 31.89 (-0.02)
Top Research Reports for Apple, Shell & Morgan Stanley
Sheraz Mian - Zacks Investment Research - Wed Aug 31, 10:32AM CDT
Top Research Reports for Apple, Shell & Morgan Stanley
KO: 43.66 (+0.31), RDS.A: 49.64 (+1.01), AAPL: 107.73 (+1.00), ORCL: 41.25 (+0.09), MS: 31.89 (-0.02), TRV: 118.84 (+0.49)
(0)
(0)Scroll down for more posts ▼